Last reviewed · How we verify
Weight loss with pharmacotherapy — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Weight loss with pharmacotherapy (Weight loss with pharmacotherapy) — TecSalud Investigación Clínica.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Weight loss with pharmacotherapy TARGET | Weight loss with pharmacotherapy | TecSalud Investigación Clínica | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Weight loss with pharmacotherapy CI watch — RSS
- Weight loss with pharmacotherapy CI watch — Atom
- Weight loss with pharmacotherapy CI watch — JSON
- Weight loss with pharmacotherapy alone — RSS
Cite this brief
Drug Landscape (2026). Weight loss with pharmacotherapy — Competitive Intelligence Brief. https://druglandscape.com/ci/weight-loss-with-pharmacotherapy. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab